Why Eli Lilly's plan to disrupt the traditional doctor-patient relationship makes us nervous.
Medical student, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PennsylvaniaAssistant Professor of Emergency Medicine, Lenox Hill Hospital, Northwell Health, New York, NYProfessor of Anesthesiology, Surgery, Neurology, and Neurosurgery, University of Rochester, Rochester, New York; Professor of Internal Medicine Mercer School of Medicine, Macon, Georgia-like peptide 1 receptor agonist akin to Mounjaro, Ozempic, and Wegovy — will be prescribed by independent telehealth...
On the surface, this design appears promising. Wait times for doctor's appointments will fall. Patients can order drugs from the comfort of their home. Everyone benefits. Or do they? Adding to these parallels, once a patient begins a GLP-1 medication such as Zepbound, stopping treatment will probably lead to regaining lost weight, serving as negative reinforcement. Hence, patients may decide never to discontinue these medications.
Furthermore, the lack of a regular physician to monitor patients introduces uncertainty in safety and continuity of care. These are important tenets in protecting patients, especially patients who are not diabetic and desire a quick fix. We have already seen a huge, arguably unrestrained, rise in prescriptions of GLP-1 RAs for weight loss — up to aexist — namely, serious gastrointestinal side effects and low blood glucose in nondiabetic persons — that an astute physician must consider.
Obese Toxicology Toxicity Poisoning Toxins Telehealth And Telemedicine Telehealth (Telemedicine) Telemedicine Telehealth Technology Remote Patient Monitoring Patient Safety Adverse Effects Side Effects Weight Management Weight Loss Practice Management Revenue Residency Residents Cardiovascular Imaging Cardiac Imaging CV Imaging Disaster Disaster Medicine Ethics
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Buy this little-known pharma stock with more than 80% upside ahead, RBC saysAnalyst Luca Issi began research coverage of the pharmaceutical company, which develops treatments for rare and ultra-rare diseases, with an outperform rating.
Read more »
European industry groups warn of shuttered factories from Biden LNG pauseEurope’s biggest gas groups are sounding the alarm over Biden's pause on new LNG exports, warning that the pause could dampen industrial activity, force factory closures, and erode trust between leaders in Brussels and Washington.
Read more »
Congress’ focus on China biotech could reshape Philadelphia area cell and gene factoriesWuXi AppTec, one of the biggest biotech employers in Philadelphia, is facing intense scrutiny from the U.S. government, pushing local companies to seek alternatives.
Read more »
InnovationRx: Legislation Could Prevent Pharma Companies From Working With Chinese ContractorsI'm a senior editor at Forbes covering healthcare, science, and cutting edge technology. I also co-author the InnovationRX newsletter.
Read more »
Workers at Mercedes factories near Tuscaloosa, Alabama, to vote in May on United Auto Workers unionWorkers at Mercedes-Benz factories near Tuscaloosa, Alabama, will vote next month on whether they want to be represented by the United Auto Workers union. The National Labor Relations Board said Thursday that the vote will take place from May 13 to May 17 at the facilities in Vance and Woodstock, Alabama. Votes will be counted May 17.
Read more »
Workers at Mercedes-Benz factories near Tuscaloosa to vote on unionizingMontgomery, Alabama
Read more »